Clinical trial
Pericapsular Nerve Group (PENG) Block Combined With Periarticular Multimodal Drug Injection (PMDI) Versus Isolated PMDI for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial
NCT05320913 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pericapsular Nerve Group (PENG) Block Combined With Periarticular Multimodal Drug Injection (PMDI) Versus Isolated PMDI for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 4, 2022
- Completion date
- December 13, 2023
- Enrollment
- 58 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
total hip arthroplasty, postoperative pain